Accessibility to ERCP-performing hospitals among patients with pancreatic cancer living in SEER regions.

Authors:
Tavakkoli A; Beauchamp A; Prasad T; Zhu H; Singal AG and 5 more

Journal:
Cancer Med

Publication Year: 2024

DOI:
10.1002/cam4.7020

PMCID:
PMC10891451

PMID:
38400670

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Cancer Med

Abbreviation: Cancer Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada.
Judd S; Revon-Riviere G; Grover SA and 17 more (2024) - Transparency Score: 3/6
A comprehensive narrative review of challenges and facilitators in the implementation of various HP…
Aggarwal S; Agarwal P; Gupta N. (2024) - Transparency Score: 3/6
A computed tomography urography-based machine learning model for predicting preoperative pathologic…
Zheng Y; Shi H; Fu S and 6 more (2024) - Transparency Score: 3/6
Actionable mutational profiling in solid tumors using hybrid-capture-based next-generation sequenci…
Zazo S; Pérez-Buira S; Carvajal N and 12 more (2024) - Transparency Score: 4/6
Anthracycline-induced cardiotoxicity on regional myocardial work and left ventricular mechanical di…
Jaber M; Armand A; Rochette E and 6 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"zip codes with a lower proportion of college educated persons (table 1"

Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT Anna Tavakkoli, Alaina Beauchamp, Tanushree Prasad, Hong Zhu, Nisa Kubiliun, Richard Kwon, and Amy Hughes disclose no conflicts of interest. Unrelated to this work, Sandi Pruitt serves as a consultant for Pfizer and Gilead, and Amit Singal has served as a consultant or on advisory boards for Genentech, AstraZeneca, Eisai, Bayer, Exelixis, Boston Scientific, Fujifilm Medical Sciences, Exact Sciences, Roche, Glycotest, Freenome, and GRAIL."

Evidence found in paper:

"FUNDING INFORMATION Anna Tavakkoli is funded by NIH 1K23DK132409‐01A1."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025